Mind Medicine (MindMed) Inc. (MNMD)
USD 5.42
(-2.43%)
USD 5.42
(-2.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -85.57 Million USD | 39.77% |
| 2022 | -142.07 Million USD | -6.39% |
| 2021 | -133.53 Million USD | -66.73% |
| 2020 | -80.09 Million USD | -446578.94% |
| 2019 | -17.93 Thousand USD | 88.42% |
| 2018 | -154.79 Thousand USD | -1415.69% |
| 2017 | 11.76 Thousand USD | 207.33% |
| 2016 | -10.96 Thousand USD | -137.15% |
| 2015 | -4622.32 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -238.14 Million USD | -178.28% |
| 2024 Q2 | -218.88 Million USD | 8.09% |
| 2023 Q4 | -85.57 Million USD | 17.42% |
| 2023 Q2 | -116.82 Million USD | 9.68% |
| 2023 Q3 | -103.63 Million USD | 11.29% |
| 2023 Q1 | -129.33 Million USD | 8.96% |
| 2023 FY | -85.57 Million USD | 39.77% |
| 2022 Q4 | -142.07 Million USD | 8.01% |
| 2022 FY | -142.07 Million USD | -6.39% |
| 2022 Q3 | -154.44 Million USD | -46.16% |
| 2022 Q1 | -120.47 Million USD | 9.79% |
| 2022 Q2 | -105.67 Million USD | 12.29% |
| 2021 Q1 | -159.99 Million USD | -99.75% |
| 2021 FY | -133.53 Million USD | -66.73% |
| 2021 Q4 | -133.53 Million USD | 8.48% |
| 2021 Q3 | -145.91 Million USD | 7.12% |
| 2021 Q2 | -157.09 Million USD | 1.81% |
| 2020 Q2 | -24.06 Million USD | -17.36% |
| 2020 Q4 | -80.09 Million USD | -339.23% |
| 2020 Q3 | -18.23 Million USD | 24.24% |
| 2020 Q1 | -20.5 Million USD | 0.0% |
| 2020 FY | -80.09 Million USD | -446578.94% |
| 2019 FY | -17.93 Thousand USD | 88.42% |
| 2018 FY | -154.79 Thousand USD | -1415.69% |
| 2017 FY | 11.76 Thousand USD | 207.33% |
| 2016 FY | -10.96 Thousand USD | -137.15% |
| 2015 FY | -4622.32 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -52.976% |
| Alkermes plc | -166.73 Million USD | 48.677% |
| Agenus Inc. | 274.13 Million USD | 131.216% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 104.576% |
| Aptorum Group Limited | 1.35 Million USD | 6405.976% |
| Ardelyx, Inc. | 34.51 Million USD | 347.957% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 2099.416% |
| Bicycle Therapeutics plc | -481.46 Million USD | 82.226% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 336.637% |
| ChromaDex Corporation | -24.04 Million USD | -255.851% |
| Chimerix, Inc. | -25.51 Million USD | -235.365% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1328.101% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -261.427% |
| CRISPR Therapeutics AG | -150.84 Million USD | 43.27% |
| Precision BioSciences, Inc. | -85.41 Million USD | -0.193% |
| Dyadic International, Inc. | -6.37 Million USD | -1241.701% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -437.093% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1216.438% |
| Lantern Pharma Inc. | -21.7 Million USD | -294.295% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 22.582% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -901.677% |
| Incyte Corporation | -3.17 Billion USD | 97.305% |
| IO Biotech, Inc. | -140.69 Million USD | 39.179% |
| Jaguar Health, Inc. | 29.39 Million USD | 391.161% |
| Novavax, Inc. | -298.29 Million USD | 71.312% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1703.429% |
| Opthea Limited | 28.15 Million USD | 403.916% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -409.709% |
| ContextLogic Inc. | -232 Million USD | 63.114% |
| MiMedx Group, Inc. | -33.9 Million USD | -152.426% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 939.382% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -3593.31% |
| NextCure, Inc. | -6.47 Million USD | -1221.214% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -69.452% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1241.511% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 803.553% |
| Vaxcyte, Inc. | -368.22 Million USD | 76.76% |
| PDS Biotechnology Corporation | -32.7 Million USD | -161.626% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 595.283% |
| Pharming Group N.V. | 109.8 Million USD | 177.934% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -391.923% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 51.164% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -362.072% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -362.072% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1105.282% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -1360.324% |
| Acelyrin, Inc. | -216.9 Million USD | 60.547% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -1425.328% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -4863.747% |
| Summit Therapeutics Inc. | 34.67 Million USD | 346.799% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1157.901% |
| Senti Biosciences, Inc. | 1.74 Million USD | 5018.103% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 53.645% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -10.489% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -1311.663% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 85873.136% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 13726.592% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 26.888% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 49.133% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 177.185% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1026.58% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 33.721% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 1341.189% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 64.691% |
| Immix Biopharma, Inc. | -17.5 Million USD | -388.727% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 72.979% |
| MEI Pharma, Inc. | -3.7 Million USD | -2209.717% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 783.998% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 152.908% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 407.901% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1216.438% |
| Precigen, Inc. | -481 Thousand USD | -17691.06% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 707.734% |
| AlloVir, Inc. | -62.69 Million USD | -36.501% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -53.873% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 238.772% |
| ImmuCell Corporation | 10.99 Million USD | 878.623% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 44.484% |
| Onconetix, Inc. | 5.33 Million USD | 1705.102% |
| PureTech Health plc | -167.19 Million USD | 48.818% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -180.942% |
| Elevation Oncology, Inc. | -19.11 Million USD | -347.615% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1643.227% |
| Seer, Inc. | -4.24 Million USD | -1918.278% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -256.014% |
| Innoviva, Inc. | 255.56 Million USD | 133.485% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -53.185% |
| ESSA Pharma Inc. | -33.62 Million USD | -154.524% |
| GlycoMimetics, Inc. | -40.98 Million USD | -108.799% |
| GT Biopharma, Inc. | -1.02 Million USD | -8281.489% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -26.248% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 239.698% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 36.176% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -517.602% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -196.394% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -113494.127% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -177.283% |
| Aptose Biosciences Inc. | -8.19 Million USD | -944.253% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -2634.884% |
| Soligenix, Inc. | -4.95 Million USD | -1628.23% |
| Century Therapeutics, Inc. | 847 Thousand USD | 10203.306% |
| Kura Oncology, Inc. | -20.11 Million USD | -325.365% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -109.097% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -918.993% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 4797.548% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -2576.728% |
| Autolus Therapeutics plc | -186.59 Million USD | 54.14% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -73.566% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 68.971% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 349.723% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 152.063% |
| GRI Bio, Inc. | -1.79 Million USD | -4670.067% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -852.628% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -157.314% |
| IGM Biosciences, Inc. | -72.6 Million USD | -17.862% |
| INmune Bio, Inc. | -25.41 Million USD | -236.764% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 156.691% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -68.924% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -426.636% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -2866.281% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 325.109% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -107.782% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 368.386% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 122.642% |
| Verastem, Inc. | -37.27 Million USD | -129.559% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -843.183% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -65.005% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -465.411% |
| Histogen Inc. | -7.48 Million USD | -1042.981% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -296.056% |
| Surrozen, Inc. | -32.66 Million USD | -161.986% |
| Organovo Holdings, Inc. | -1.5 Million USD | -5578.5% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1935.809% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 551.34% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 3371.216% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 2159.071% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -921.041% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -96.987% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -487.061% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 72.987% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -11751.508% |
| Apollomics, Inc. | -27.39 Million USD | -212.375% |
| Amarin Corporation plc | -191.04 Million USD | 55.206% |
| Mesoblast Limited | 55.96 Million USD | 252.914% |
| Turnstone Biologics Corp. | -14.58 Million USD | -486.773% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -238.348% |
| Synaptogenix, Inc. | -28.66 Million USD | -198.571% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -9042.628% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 275.603% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -9826.469% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1077.733% |
| Exelixis, Inc. | -73.05 Million USD | -17.146% |
| Better Therapeutics, Inc. | -860 Thousand USD | -9850.581% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -256.369% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 64.546% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 11725.995% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1050.49% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 6924.163% |
| Gritstone bio, Inc. | 39.49 Million USD | 316.7% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -1.753% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -3151.157% |
| Avid Bioservices, Inc. | 169.72 Million USD | 150.419% |
| Insmed Incorporated | 721.62 Million USD | 111.859% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -836.114% |
| MediWound Ltd. | -5.32 Million USD | -1507.948% |
| OmniAb, Inc. | 9.2 Million USD | 1029.86% |
| Alector, Inc. | -35.63 Million USD | -140.13% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 199.539% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1636.506% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 746.386% |
| Zai Lab Limited | -775 Million USD | 88.958% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 125.128% |
| Aura Biosciences, Inc. | -21.52 Million USD | -297.561% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -3.752% |
| Immunic, Inc. | -45.34 Million USD | -88.741% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 55.71% |
| Veracyte, Inc. | -203.82 Million USD | 58.015% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 113.407% |
| FibroGen, Inc. | 56.76 Million USD | 250.748% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1060.977% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -2926.973% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -4033.363% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 101.864% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -2461.359% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 48.438% |
| TG Therapeutics, Inc. | 17.86 Million USD | 579.09% |
| Galecto, Inc. | -21.21 Million USD | -303.351% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -259.786% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 105.453% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -249.685% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -643.678% |
| XBiotech Inc. | -200.02 Million USD | 57.217% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -1.753% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 1989.907% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -142.676% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -10.823% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1603.69% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 49.784% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 7.36% |
| Vaxxinity, Inc. | 10.13 Million USD | 944.601% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 111.623% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -694.749% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -29.746% |
| NexImmune, Inc. | -3.13 Million USD | -2630.847% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -2378.514% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -466.292% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -215.775% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -853.37% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -68593.558% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -110.921% |
| Ainos, Inc. | 4.07 Million USD | 2198.492% |
| Pluri Inc. | 22.82 Million USD | 474.852% |
| Prothena Corporation plc | -608.34 Million USD | 85.933% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 27.94% |
| Celularity Inc. | 65.19 Million USD | 231.27% |
| Rallybio Corporation | -24.1 Million USD | -255.054% |
| Cue Biopharma, Inc. | -33.81 Million USD | -153.038% |
| MeiraGTx Holdings plc | -40.3 Million USD | -112.334% |
| Omeros Corporation | 331.17 Million USD | 125.84% |
| Humacyte, Inc. | -22.48 Million USD | -280.57% |
| Immunocore Holdings plc | -358.59 Million USD | 76.136% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -248.22% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -176.933% |
| Blueprint Medicines Corporation | 702.83 Million USD | 112.176% |
| CalciMedica, Inc. | -5.53 Million USD | -1447.468% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 54.535% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -737.821% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -113.74% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -157.345% |
| Pulmatrix, Inc. | -10.41 Million USD | -721.494% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -1331.738% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -124.359% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 23.184% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -42.758% |
| Cytokinetics, Incorporated | 642.37 Million USD | 113.322% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -1369.603% |
| Nutriband Inc. | -251.65 Thousand USD | -33904.617% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -150.813% |
| Vor Biopharma Inc. | 4.3 Million USD | 2090.116% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 98.582% |
| Evogene Ltd. | -19.63 Million USD | -335.851% |
| ProKidney Corp. | -56.23 Million USD | -52.171% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -75.82% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -826.418% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 106.274% |
| CorMedix Inc. | -43.05 Million USD | -98.769% |
| BioLineRx Ltd. | 7.33 Million USD | 1266.508% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -211.578% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 285.44% |
| Atai Life Sciences N.V. | -28.55 Million USD | -199.653% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 3936.534% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -275.066% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 582.52% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -13.988% |
| MediciNova, Inc. | -50.78 Million USD | -68.509% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -8.591% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -380317.871% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1226.212% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 57.174% |
| Biomea Fusion, Inc. | -166.57 Million USD | 48.625% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 52.186% |
| Mereo BioPharma Group plc | -51.46 Million USD | -66.265% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 9.773% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 70.869% |
| Absci Corporation | -72.59 Million USD | -17.875% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1974.179% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 63.498% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 9.167% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 10.576% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -119.013% |
| Allakos Inc. | -24.97 Million USD | -242.643% |
| Imunon, Inc. | -4.21 Million USD | -1930.802% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -480.484% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 36.798% |
| BioAtla, Inc. | -109.01 Million USD | 21.499% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 11725.995% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -9013.419% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 815.151% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -303.599% |
| XOMA Corporation | -29 Million USD | -195.086% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -416.757% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -849.146% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1048.812% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 31.34% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 58.891% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -4.642% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 7.749% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -9860.032% |
| Akari Therapeutics, Plc | -3.84 Million USD | -2125.618% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5373.001% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 106.197% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7102.464% |
| UroGen Pharma Ltd. | 4.39 Million USD | 2048.873% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 175.409% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 119016.928% |
| Orgenesis Inc. | 21.78 Million USD | 492.834% |
| Entera Bio Ltd. | -10.62 Million USD | -705.109% |
| GH Research PLC | -78.07 Million USD | -9.603% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -283.951% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -220.999% |
| Xencor, Inc. | 29.64 Million USD | 388.676% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -4244.323% |
| Replimune Group, Inc. | 1.41 Million USD | 6160.552% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -34841.692% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 32.307% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -7102.464% |
| Portage Biotech Inc. | -4.98 Million USD | -1618.029% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -380317.871% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -29.42% |
| OncoCyte Corporation | -6.56 Million USD | -1203.901% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 9635.743% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -1778.44% |
| Purple Biotech Ltd. | -14.13 Million USD | -505.284% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -260.225% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1207.487% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -412.666% |
| HilleVax, Inc. | -165.48 Million USD | 48.288% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -3271.749% |
| Tharimmune, Inc. | -10.93 Million USD | -682.554% |
| Genprex, Inc. | -6.73 Million USD | -1170.106% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 76.797% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 3.261% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -6008.137% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -2479.933% |
| OKYO Pharma Limited | -826.84 Thousand USD | -10249.544% |
| Savara Inc. | 153 Thousand USD | 56031.373% |
| Curis, Inc. | -23.88 Million USD | -258.249% |
| Daré Bioscience, Inc. | -5.15 Million USD | -1559.102% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -10927.536% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -1278.463% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 7321.519% |
| BeiGene, Ltd. | -2.25 Billion USD | 96.202% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 793.561% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 85.93% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 53.889% |
| Erasca, Inc. | -37.21 Million USD | -129.941% |
| bluebird bio, Inc. | 108.57 Million USD | 178.819% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -6544.574% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 122.594% |
| DBV Technologies S.A. | -126.98 Million USD | 32.611% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -6544.574% |
| Moderna, Inc. | -2.9 Billion USD | 97.056% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -726.652% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -687.403% |
| Molecular Templates, Inc. | 707 Thousand USD | 12203.96% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -172.784% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 124.689% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -4.281% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 6.71% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -165.168% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -148.938% |
| MacroGenics, Inc. | -66.98 Million USD | -27.752% |
| RenovoRx, Inc. | -1.17 Million USD | -7195.396% |
| Adicet Bio, Inc. | -138.78 Million USD | 38.341% |
| Prime Medicine, Inc. | -27.94 Million USD | -206.27% |
| Aditxt, Inc. | 18.12 Million USD | 572.245% |
| Adagene Inc. | -87.62 Million USD | 2.342% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1954.411% |
| Quantum-Si incorporated | -118.55 Million USD | 27.82% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 337.675% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1044.94% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -76.411% |
| SciSparc Ltd. | -2.06 Million USD | -4044.068% |
| Vericel Corporation | 1.27 Million USD | 6801.253% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -613.619% |
| Minerva Neurosciences, Inc. | 41 Million USD | 308.698% |
| Generation Bio Co. | 31.44 Million USD | 372.116% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 51.202% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -176.736% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 173.396% |
| Invivyd, Inc. | -198.47 Million USD | 56.884% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 5.201% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -3469.063% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -20.886% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1153.846% |
| 2seventy bio, Inc. | 181.71 Million USD | 147.093% |
| ADMA Biologics, Inc. | 90.06 Million USD | 195.014% |
| Clene Inc. | 3.34 Million USD | 2662.126% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -842.175% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -297.82% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1226.212% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 75.133% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -229.139% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 148.166% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -1991.497% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 1810.816% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -1542.83% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 34.327% |
| Evaxion Biotech A/S | 5.28 Million USD | 1718.641% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 23.979% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 34.811% |
| Trevena, Inc. | 2.25 Million USD | 3889.858% |
| Surrozen, Inc. | -32.66 Million USD | -161.986% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -66.133% |
| Cingulate Inc. | 3.08 Million USD | 2875.991% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -2813.687% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1290.692% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -821.03% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -7.882% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 34.9% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 18.919% |
| Clearmind Medicine Inc. | -3.94 Million USD | -2070.502% |
| Kronos Bio, Inc. | -36.05 Million USD | -137.352% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1009.502% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 5968.83% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -57.724% |
| Statera Biopharma, Inc. | 14.41 Million USD | 693.595% |
| ImmunityBio, Inc. | 618.22 Million USD | 113.842% |
| Korro Bio, Inc. | -132.94 Million USD | 35.63% |
| Kineta, Inc. | -4.54 Million USD | -1784.497% |
| BioVie Inc. | -17.73 Million USD | -382.593% |
| Codexis, Inc. | -43.27 Million USD | -97.765% |
| Celularity Inc. | 65.19 Million USD | 231.27% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -2600.379% |
| Celcuity Inc. | 6.78 Million USD | 1361.515% |
| Virax Biolabs Group Limited | -3.36 Million USD | -2443.133% |
| Cibus, Inc. | -8.07 Million USD | -959.359% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -1923.528% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 1972.538% |
| IN8bio, Inc. | -16.38 Million USD | -422.149% |
| Kodiak Sciences Inc. | -103.87 Million USD | 17.617% |
| Annexon, Inc. | -193.75 Million USD | 55.833% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 237808.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -389.028% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -2335.952% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 108.117% |
| Eyenovia, Inc. | 1.25 Million USD | 6898.67% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 418.064% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2538.76% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -157.392% |
| Arcellx, Inc. | -296.95 Million USD | 71.183% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -338.711% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -45.35% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -312.867% |
| Moolec Science SA | 117.61 Thousand USD | 72857.958% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -122.857% |
| Geron Corporation | 14.76 Million USD | 679.737% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -125.684% |
| Royalty Pharma plc | 5.65 Billion USD | 101.512% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 39.489% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1124.35% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -1495.697% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 39.193% |
| Humacyte, Inc. | -22.48 Million USD | -280.57% |
| Structure Therapeutics Inc. | -124.33 Million USD | 31.176% |
| 89bio, Inc. | -289.05 Million USD | 70.395% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -239.018% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -4699.495% |
| Genelux Corporation | -6.89 Million USD | -1140.397% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -175.524% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 202.364% |
| Notable Labs, Ltd. | -9.77 Million USD | -775.358% |
| Liquidia Corporation | -80.17 Million USD | -6.734% |
| Mustang Bio, Inc. | -3.73 Million USD | -2190.551% |
| Immunovant, Inc. | -635.22 Million USD | 86.528% |
| Quantum-Si incorporated | -118.55 Million USD | 27.82% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -387.218% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -1965.532% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1166.089% |
| Acasti Pharma Inc. | -23 Million USD | -271.984% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -2441.407% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -426.636% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 37.872% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -2645.99% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -284.918% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -360.849% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 49.447% |
| PepGen Inc. | -60.67 Million USD | -41.05% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -272.454% |
| United Therapeutics Corporation | -507.7 Million USD | 83.145% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -347.428% |
| Solid Biosciences Inc. | -47.75 Million USD | -79.215% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -9826.469% |
| Immuneering Corporation | -54.94 Million USD | -55.753% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1935.809% |
| Silo Pharma, Inc. | -3.52 Million USD | -2328.136% |
| Belite Bio, Inc | -87.27 Million USD | 1.943% |
| XOMA Corporation | -29 Million USD | -195.086% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -21.045% |
| Bionomics Limited | 227 Million USD | 137.697% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 26.407% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3278.405% |
| uniQure N.V. | -102.95 Million USD | 16.878% |
| Cassava Sciences, Inc. | -121.13 Million USD | 29.356% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1954.411% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 308.969% |
| Forte Biosciences, Inc. | -11.96 Million USD | -615.45% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -2665.658% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 80831.132% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -2538.76% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1060.977% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1053.924% |
| Altimmune, Inc. | -134.48 Million USD | 36.369% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 143.206% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -3278.405% |
| Compugen Ltd. | -12.9 Million USD | -563.166% |
| Peak Bio, Inc. | 10.34 Million USD | 927.599% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -30138.516% |
| Benitec Biopharma Inc. | -50.58 Million USD | -69.181% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 17.983% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 535.607% |
| Zura Bio Limited | -99.8 Million USD | 14.259% |
| PolyPid Ltd. | 6.17 Million USD | 1486.953% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 215.455% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 535.607% |
| Instil Bio, Inc. | 75.35 Million USD | 213.558% |
| argenx SE | -2.02 Billion USD | 95.782% |
| Immunome, Inc. | -97.02 Million USD | 11.805% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -280.418% |
| Verona Pharma plc | -220.44 Million USD | 61.18% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -19.28% |
| Shattuck Labs, Inc. | -121.42 Million USD | 29.524% |
| CervoMed Inc. | -7.79 Million USD | -998.123% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 53.868% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -1856.895% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 35.043% |
| Moolec Science SA | 117.61 Thousand USD | 72857.958% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -3640.204% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 638.262% |
| AnaptysBio, Inc. | -18.15 Million USD | -371.462% |
| Design Therapeutics, Inc. | -18.15 Million USD | -371.488% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -21.588% |
| NeurAxis, Inc. | 145.7 Thousand USD | 58833.699% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 861.886% |
| Lumos Pharma, Inc. | -28.49 Million USD | -200.337% |
| Achilles Therapeutics plc | -126.92 Million USD | 32.578% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -19.28% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -12950.341% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -311.937% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 5968.83% |
| Nutriband Inc. | -251.65 Thousand USD | -33904.617% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -549.723% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1050.202% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 125.155% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 460.544% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 80.876% |
| Palisade Bio, Inc. | -12.06 Million USD | -609.401% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 39.01% |
| Beam Therapeutics Inc. | -262.72 Million USD | 67.428% |
| Neurogene Inc. | -131.95 Million USD | 35.148% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 492.258% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1653.586% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 77.313% |
| Sesen Bio, Inc. | -112.55 Million USD | 23.969% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 14.305% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -3544.912% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -119.277% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -2.753% |
| Athira Pharma, Inc. | -88.99 Million USD | 3.847% |
| Vaccinex, Inc. | -1.28 Million USD | -6544.022% |
| HCW Biologics Inc. | 2.85 Million USD | 3095.614% |
| XOMA Corporation | -29 Million USD | -195.086% |
| Nektar Therapeutics | 210.24 Million USD | 140.703% |
| Arvinas, Inc. | -313.8 Million USD | 72.729% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 5373.001% |
| Merus N.V. | -192.88 Million USD | 55.634% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 242.661% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1133.425% |
| Rezolute, Inc. | -68.16 Million USD | -25.535% |
| Clene Inc. | 3.34 Million USD | 2662.126% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -548.935% |
| BeyondSpring Inc. | -13.75 Million USD | -522.137% |
| Synlogic, Inc. | -6.68 Million USD | -1180.105% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 7646.296% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -912.123% |
| Peak Bio, Inc. | 10.34 Million USD | 927.599% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -3.828% |
| Krystal Biotech, Inc. | -350.23 Million USD | 75.566% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 168.943% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 49.363% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -2610.519% |
| MannKind Corporation | 143.89 Million USD | 159.469% |
| Ikena Oncology, Inc. | -109.15 Million USD | 21.603% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1030.3% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -158.535% |
| Gossamer Bio, Inc. | 180.35 Million USD | 147.448% |
| CohBar, Inc. | -5.93 Million USD | -1342.908% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -187.666% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1974.179% |
| Legend Biotech Corporation | -949.39 Million USD | 90.986% |
| Mural Oncology plc | -255.84 Million USD | 66.552% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 365.637% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -1716.631% |
| Disc Medicine, Inc. | -358.28 Million USD | 76.115% |
| Champions Oncology, Inc. | 4.81 Million USD | 1878.367% |
| REGENXBIO Inc. | 54.76 Million USD | 256.25% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -31723.27% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 43.337% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -849.567% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -6.063% |
| Vaxart, Inc. | -8.24 Million USD | -938.406% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -70.536% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 32.706% |
| Cellectis S.A. | -43.85 Million USD | -95.132% |
| Longeveron Inc. | -2.9 Million USD | -2842.744% |
| Repare Therapeutics Inc. | -107.85 Million USD | 20.66% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 108.837% |
| Inozyme Pharma, Inc. | 12 Million USD | 812.887% |
| Revolution Medicines, Inc. | -608.2 Million USD | 85.93% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -6857.317% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 67.722% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 42.977% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -446.91% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -11464.189% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.105% |
| Denali Therapeutics Inc. | -74.86 Million USD | -14.306% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -613.619% |
| Veru Inc. | 4.77 Million USD | 1890.284% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -660.937% |
| Cingulate Inc. | 3.08 Million USD | 2875.991% |
| Passage Bio, Inc. | 4.58 Million USD | 1966.412% |
| Context Therapeutics Inc. | -14.44 Million USD | -492.222% |
| Exicure, Inc. | 5.84 Million USD | 1563.071% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 62.854% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -116.262% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 645.376% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -45.484% |
| Nuvalent, Inc. | -335.38 Million USD | 74.485% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 5034.151% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -14.894% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -862.598% |
| OmniAb, Inc. | 9.2 Million USD | 1029.86% |
| Anew Medical, Inc. | 1.43 Million USD | 6073.968% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 622.38% |
| Lipocine Inc. | -4.75 Million USD | -1699.839% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 22.083% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 661.848% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -68.924% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 443.785% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1173.248% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -30.0% |
| Ocugen, Inc. | -32.52 Million USD | -163.138% |
| Q32 Bio Inc. | -37.94 Million USD | -125.506% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -13526.592% |
| Alumis Inc. Common Stock | -13.52 Million USD | -532.53% |
| Equillium, Inc. | -22.39 Million USD | -282.168% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -234.696% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -162.285% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -34417.879% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 163.842% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 2775.891% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 26154.908% |
| Dominari Holdings Inc. | 195 Thousand USD | 43984.615% |
| Edesa Biotech, Inc. | -5.26 Million USD | -1524.767% |
| vTv Therapeutics Inc. | -8.91 Million USD | -859.684% |
| Bio-Techne Corporation | 267.74 Million USD | 131.961% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -427.947% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 27.537% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -918.386% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -576.429% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 65.088% |
| Nkarta, Inc. | 57.29 Million USD | 249.348% |
| BioCardia, Inc. | 212 Thousand USD | 40465.566% |
| Iterum Therapeutics plc | 13.43 Million USD | 736.814% |